DOI:
10.1055/s-00000059
Pneumologie
LinksClose Window
References
Berger W, Gupta N, McAlary M. et al.
Evaluation of long-term safety of the anti-IgE antibody, omalizumab, in children with allergic asthma.
Ann Allergy Asthma Immunol 2003; 91: 182-188
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.